Molecular mechanisms for curcumin benefits against ischemic injury.
Sahebkar
Amirhossein
A
D000818:Animals; D004396:Coloring Agents / Q000494:pharmacology / Q000627:therapeutic use; D003474:Curcumin / Q000494:pharmacology / Q000627:therapeutic use*; D019040:E-Selectin / Q000378:metabolism; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D016169:Lymphocyte Function-Associated Antigen-1 / Q000378:metabolism; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D023421:Models, Animal; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D015427:Reperfusion Injury / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control*; D013086:Spermatic Cord Torsion / Q000150:complications*; D013737:Testis / Q000098:blood supply*
D004396:Coloring Agents; D019040:E-Selectin; D016169:Lymphocyte Function-Associated Antigen-1; D017382:Reactive Oxygen Species; D018799:Intercellular Adhesion Molecule-1; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D003474:Curcumin